What You Will Do We are seeking a highly skilled and motivated SAP Master Data and Material Planning Specialist... to join our İzmir Plant. The successful candidate will be responsible for managing and optimizing our SAP master data and material...
forecast accuracy Routine audits of SAP costing modules including routings and BOM's. Provide leadership to correct errors... (MFGPro preferred, SAP, Oracle or equivalent). Advanced Excel and Powerpoint user Has developed financial modeling...
up relevant allocation cycles in SAP. Provide all judgement based content (e.g. accruals, provisions, corrections... experience in statutory audits. SAP experience is preferred. A team player with a critical and continuous improvement mindset...
SAP S/4 Hana, ERP geçiş sürecine baştan sona destek vermek ve kurulum sonrasında tüm SAP süreçlerinde yer almak, SAP... Teknolojileri bölüm mezuniyeti, Benzer bir görevde en az 5 yıl tecrübe kazanmış, SAP Abap diline uzmanlık seviyesinde hakim olmak...
Chile, home to the world’s biggest lithium reserves, is confident that investors will compete for licenses to drill new deposits even amid a worsening global glut that’s squeezing the battery-metal industry. Continue Reading »
Gold Prices Today: Gold of 99.9 and 99.5 per cent purity grew ₹2,320 each in the last seven trading sessions. However, silver prices declined ₹500 to ₹93,500 per kg from the previous close Continue Reading »
At 11:57 a.m. ET, the Dow Jones Industrial Average rose 0.58 per cent, the S&P 500 gained 0.14 per cent, the Nasdaq Composite lost 0.19 per cent Continue Reading »
Expert view: Mohit Khanna anticipates the Union Budget 2025 will prioritize youth, women, the poor, and farmers, with increased spending on rural housing, irrigation, and employment-linked incentives. Continue Reading »
HPCL Q3 Results: The state-owned OMC's revenue from operations in the third quarter of current fiscal rose to ₹1.10 lakh crore led by better marketing margins. Continue Reading »
Dr Reddy's Laboratories reported a 2% YoY increase in PAT to ₹1,413.3 crore for Q3 2024, driven by a 16% rise in revenue to ₹8,358.6 crore. The company invested ₹6.7 billion in R&D, focusing on complex generics and biosimilars. Continue Reading »